CD44 and breast carcinoma: In an initial study we used the ATM inhibitor KU-55933 [43] and showed significantly decreased radiation resistance of the CD44+/CD24− subset isolated both from of the MDA-MB-231 cell line and the primary culture of patient breast cancer cells.